BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 35531115)

  • 1. Abnormal spindle-like microcephaly-associated protein promotes proliferation by regulating cell cycle in epithelial ovarian cancer.
    Wu Y; You Y; Chen L; Liu Y; Liu Y; Lou W; Fu F
    Gland Surg; 2022 Apr; 11(4):687-701. PubMed ID: 35531115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deregulation of microcephalin and ASPM expression are correlated with epithelial ovarian cancer progression.
    Alsiary R; Brüning-Richardson A; Bond J; Morrison EE; Wilkinson N; Bell SM
    PLoS One; 2014; 9(5):e97059. PubMed ID: 24830737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ASPM and microcephalin expression in epithelial ovarian cancer correlates with tumour grade and survival.
    Brüning-Richardson A; Bond J; Alsiary R; Richardson J; Cairns DA; McCormack L; Hutson R; Burns P; Wilkinson N; Hall GD; Morrison EE; Bell SM
    Br J Cancer; 2011 May; 104(10):1602-10. PubMed ID: 21505456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
    Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
    J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of the ASPM gene is associated with aggressiveness and poor outcome in bladder cancer.
    Xu Z; Zhang Q; Luh F; Jin B; Liu X
    Oncol Lett; 2019 Feb; 17(2):1865-1876. PubMed ID: 30675249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cysteine-Rich Intestinal Protein 1 Served as an Epithelial Ovarian Cancer Marker via Promoting Wnt/
    Liu Y; Li W; Luo J; Wu Y; Xu Y; Chen T; Zhang W; Fu F
    Dis Markers; 2021; 2021():3566749. PubMed ID: 34413913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KDF1 Promoted Proliferation and Metastasis of Epithelial Ovarian Cancer
    Zhu C; Liu Y; Tong R; Guan J
    Front Genet; 2022; 13():808100. PubMed ID: 35281796
    [No Abstract]   [Full Text] [Related]  

  • 8. Overexpression of abnormal spindle-like microcephaly-associated (ASPM) increases tumor aggressiveness and predicts poor outcome in patients with lung adenocarcinoma.
    Feng Z; Zhang J; Zheng Y; Liu J; Duan T; Tian T
    Transl Cancer Res; 2021 Feb; 10(2):983-997. PubMed ID: 35116426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition.
    Lu DH; Yang J; Gao LK; Min J; Tang JM; Hu M; Li Y; Li ST; Chen J; Hong L
    Oncol Rep; 2019 Feb; 41(2):917-927. PubMed ID: 30483796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of solute-carrier family 27A molecules (SCL27As) as a potential biomarker of ovarian cancer based on bioinformatics and experiments.
    Chen H; Han T; Zhao Y; Feng L
    Ann Transl Med; 2021 Aug; 9(15):1237. PubMed ID: 34532374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CDC20 is a novel biomarker for improved clinical predictions in epithelial ovarian cancer.
    Xi X; Cao T; Qian Y; Wang H; Ju S; Chen Y; Chen T; Yang J; Liang B; Hou S
    Am J Cancer Res; 2022; 12(7):3303-3317. PubMed ID: 35968331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High expression of TRIM24 predicts worse prognosis and promotes proliferation and metastasis of epithelial ovarian cancer.
    Zhang L; Chen H; Ding B; Jiang W
    J Ovarian Res; 2022 Feb; 15(1):19. PubMed ID: 35105347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GADD45B Facilitates Metastasis of Ovarian Cancer Through Epithelial-Mesenchymal Transition.
    Gong L; Cai L; Li G; Cai J; Yi X
    Onco Targets Ther; 2021; 14():255-269. PubMed ID: 33469306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Capn4 Enhances Osteopontin Expression through Activation of the Wnt/β-Catenin Pathway to Promote Epithelial Ovarian Carcinoma Metastasis.
    Yang X; Sun J; Xia D; Can X; Liu L; Zhang J; Xu H; Du N; Liu W; Shen F; Zhang Z; Sun Y; Xi X
    Cell Physiol Biochem; 2017; 42(1):185-197. PubMed ID: 28535511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inhibitory effect of KIAA1456 on the proliferation and metastasis of epithelial ovarian cancer through SSX1 and AKT signaling pathway.
    Zhang Y; Sun C; Gao Y; Mao Y; Wu B; Li C; Zhang W; Wang J
    J Cancer; 2023; 14(5):770-783. PubMed ID: 37056382
    [No Abstract]   [Full Text] [Related]  

  • 16. CAP1 is overexpressed in human epithelial ovarian cancer and promotes cell proliferation.
    Hua M; Yan S; Deng Y; Xi Q; Liu R; Yang S; Liu J; Tang C; Wang Y; Zhong J
    Int J Mol Med; 2015 Apr; 35(4):941-9. PubMed ID: 25652936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TET1 inhibits EMT of ovarian cancer cells through activating Wnt/β-catenin signaling inhibitors DKK1 and SFRP2.
    Duan H; Yan Z; Chen W; Wu Y; Han J; Guo H; Qiao J
    Gynecol Oncol; 2017 Nov; 147(2):408-417. PubMed ID: 28851501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low BCL9 expression inhibited ovarian epithelial malignant tumor progression by decreasing proliferation, migration, and increasing apoptosis to cancer cells.
    Wang J; Zheng M; Zhu L; Deng L; Li X; Gao L; Wang C; Wang H; Liu J; Lin B
    Cancer Cell Int; 2019; 19():330. PubMed ID: 31827404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting Cyclin D1 and CDK6.
    Xia B; Yang S; Liu T; Lou G
    Mol Cancer; 2015 Mar; 14():57. PubMed ID: 25889927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-33 predicts poor prognosis and promotes ovarian cancer cell growth and metastasis through regulating ERK and JNK signaling pathways.
    Tong X; Barbour M; Hou K; Gao C; Cao S; Zheng J; Zhao Y; Mu R; Jiang HR
    Mol Oncol; 2016 Jan; 10(1):113-25. PubMed ID: 26433471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.